[ALNY] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
09-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -101.59%
YoY- -40.24%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 8,709 8,685 7,295 8,687 20,884 20,614 26,617 -16.97%
PBT -90,129 -71,352 -44,389 -21,053 -12,956 -13,824 -14,861 35.00%
Tax -2,092 431 -315 -2,884 -2,855 -1,593 -229 44.53%
NP -90,129 -71,783 -44,074 -18,169 -12,956 -13,824 -14,632 35.35%
Tax Rate - - - - - - - -
Total Cost 98,838 80,468 51,369 26,856 33,840 34,438 41,249 15.66%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -1,034.89 -826.52 -604.17 -209.15 -62.04 -67.06 -54.97 63.03%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -1.05 -0.85 -0.58 -0.29 -0.25 -0.33 -0.35 20.07%
EPS Diluted -1.05 -0.85 -0.58 -0.29 -0.25 -0.33 -0.35 20.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.